HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cristina Legnani Selected Research

fibrin fragment D (D-dimer)

4/2024D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results.
3/2024Sex Differences in Clinical Presentation of Lower Extremity Deep Vein Thrombosis.
1/2023COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study.
12/2022D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study.
1/2022Thrombotic burden, D-dimer levels and complete compression ultrasound for diagnosis of acute symptomatic deep vein thrombosis of the lower limbs.
1/2019D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants.
7/2017Cost-minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D-dimer for exclusion of venous thromboembolism.
4/2017Diagnostic Accuracy of a New d-Dimer Assay (Sclavo Auto d-Dimer) for Exclusion of Deep Vein Thrombosis in Symptomatic Outpatients.
1/2016Duration of anticoagulation after isolated pulmonary embolism.
4/2015D-dimer for the diagnosis of upper extremity deep and superficial venous thrombosis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cristina Legnani Research Topics

Disease

42Venous Thromboembolism
04/2024 - 01/2002
22Venous Thrombosis (Deep-Vein Thrombosis)
03/2024 - 01/2003
10Thrombosis (Thrombus)
05/2016 - 06/2002
9Pulmonary Embolism
12/2022 - 10/2006
8Hemorrhage
04/2024 - 01/2019
7Thrombophilia
08/2012 - 05/2003
5Thrombocytopenia (Thrombopenia)
10/2023 - 08/2010
4Atrial Fibrillation
02/2024 - 01/2016
3Neoplasms (Cancer)
11/2009 - 01/2002
2Autoimmune Diseases (Autoimmune Disease)
01/2015 - 06/2010
2Thromboembolism
02/2014 - 10/2006
2Hyperhomocysteinemia
01/2013 - 09/2006
2Activated Protein C Resistance (APC Resistance)
03/2005 - 06/2003
1COVID-19
01/2023
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2021
1Uterine Hemorrhage (Uterine Bleeding)
01/2021
1Varicose Veins (Varicose Vein)
02/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2013
1Homocystinuria
01/2013
1Ischemic Stroke
11/2012
1Patent Foramen Ovale
11/2012
1Stroke (Strokes)
11/2012
1Coumarin Resistance
08/2012
1Spontaneous Abortion (Miscarriage)
03/2012
1Hypertension (High Blood Pressure)
06/2010
1Chronic Obstructive Pulmonary Disease (COPD)
06/2010
1Multiple Myeloma
06/2010
1Vascular Diseases (Vascular Disease)
06/2010
1Obesity
06/2010
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2010
1Reperfusion Injury
03/2004
1Inflammation (Inflammations)
03/2004
1Cardiovascular Diseases (Cardiovascular Disease)
06/2002

Drug/Important Bio-Agent (IBA)

30fibrin fragment D (D-dimer)IBA
04/2024 - 01/2002
16AnticoagulantsIBA
02/2024 - 01/2002
9Vitamin KFDA Link
01/2021 - 10/2006
7factor V LeidenIBA
01/2021 - 06/2003
6Prothrombin (Factor II)IBA
01/2021 - 02/2002
5Heparin (Liquaemin)FDA LinkGeneric
10/2023 - 02/2002
5SuspensionsIBA
06/2010 - 05/2005
4Warfarin (Coumadin)FDA LinkGeneric
07/2021 - 06/2010
4Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
03/2016 - 12/2009
4Fumigant 93 (D-D)IBA
01/2010 - 05/2005
3apixabanIBA
04/2024 - 01/2016
3Factor VIII (Coagulation Factor VIII)IBA
01/2008 - 11/2004
2CreatinineIBA
10/2021 - 01/2016
2Factor V (Coagulation Factor V)IBA
01/2021 - 11/2012
2RivaroxabanIBA
01/2016 - 10/2015
2AntithrombinsIBA
10/2015 - 09/2006
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2015 - 03/2012
2Protein CIBA
03/2005 - 04/2004
2Oral ContraceptivesIBA
11/2004 - 04/2004
1insulin receptor-related receptor (IRR)IBA
04/2024
1cupric sulfide (CuS)IBA
03/2024
1Hemoglobins (Hemoglobin)IBA
10/2021
1glucuronyl glucosamine glycan sulfate (sulodexide)IBA
03/2021
1GlycosaminoglycansIBA
03/2021
1edoxabanIBA
03/2019
1Indicators and Reagents (Reagents)IBA
07/2017
1IodoacetamideIBA
05/2016
1AmmoniaIBA
05/2016
1DabigatranFDA Link
01/2016
1ThrombinFDA Link
10/2015
1Enoxaparin (Lovenox)FDA LinkGeneric
10/2015
1FluxumIBA
02/2014
1parnaparinIBA
02/2014
1Betaine (C.B.B.)FDA Link
01/2013
1Vitamin B Complex (B Vitamins)IBA
01/2013
1Contraceptive Agents (Contraceptives)IBA
11/2012
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
08/2012
1TESIBA
10/2011
1AntibodiesIBA
08/2010
1Fondaparinux (Arixtra)FDA Link
08/2010
1snake venom protein C activatorIBA
08/2010
1Thalidomide (Thalomid)FDA Link
06/2010
1Dexamethasone (Maxidex)FDA LinkGeneric
06/2010
1Biomarkers (Surrogate Marker)IBA
11/2009
1Hemostatics (Antihemorrhagics)IBA
11/2009
1Matrix Metalloproteinases (MMPs)IBA
03/2004
1Aprotinin (Trasylol)FDA Link
03/2004
1Fibrinogen (Factor I)FDA Link
05/2003
1HomocysteineIBA
06/2002
1Snake Venoms (Snake Venom)IBA
02/2002

Therapy/Procedure

10Therapeutics
11/2021 - 01/2002
2Liver Transplantation
03/2004 - 06/2003
1Hormonal Contraception
01/2021
1Stem Cell Transplantation
06/2010
1Bariatric Surgery
12/2009
1Contraception (Birth Control)
05/2003